glp 1 alternative over the counter Patients Are Left With Few Options as GLP-1 Copycats Disappear Oral GLP-1 Orforglipron Is Approved
Description
Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trial

Clinical decisions should be individualized based on patient preferences, comorbidities, medication regimens, and treatment goals, with ongoing medical supervision to monitor safety and efficacy
Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al

Acta Neuropsychiatr

Understanding this shift helps patients recognize why GLP-1 compounds have become a cornerstone of modern precision medicine
